Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT00807794
Eligibility Criteria:
Inclusion Criteria:
* Renal allograft recipients receiving their first or second allograft
* Age over 18
* Maintained on conventional immunosuppression
* Completed informed consent document
Exclusion Criteria:
* Known hypersensitivity to MEDI-507
* More than two renal allografts
* Moribund and unlikely (in the opinion of the investigator) to survive the duration of the trial
* Simultaneous use of other investigational agents (this does not include the use of licensed agents for indications not listed in the package insert)
* Any of the following clinical settings or diagnoses posttransplant:
pregnancy or nursing mother: Ø Human Immunodeficiency Virus infection Ø hemodialysis or chronic peritoneal dialysis Ø use of a ventilator Ø hyperacute rejection
* Having received OKT3, tacrolimus, or antilymphocyte globulin during the current allograft
* Less than 10 ml/hr average urine output over 4 hours since the end of surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00807794
Study Brief:
Protocol Section:
NCT00807794